12:00 AM
 | 
May 03, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Myriad Pharmaceuticals preclinical data

In a mouse xenograft model of human colon carcinoma, a single 50 or 75 mg/kg dose of oral...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >